BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Dr Supriya Kulkarni speaks to ecancer in an online interview for the virtual BGICC 2021 meeting about the topic of pre-operative staging with breast MRI.
She explains that there is increased utilisation of breast MRI all over the world and it is important to assess the exact indications in which this could be offered.
Dr Kulkarni believes that it is important to understand that breast MRI should be used targeted to individual groups of women where the benefit will be maximum, such as invasive lobular breast cancers and women who are considered high-risk.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
Insights into germline genetic screening of breast cancer patients
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Best practice in HRRm testing in patients with metastatic prostate cancer
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
Choosing Wisely in radiology Tanzania
Why tumour markers are not recommended as screening tests
Overview of the management of HER2-low breast cancer patients